Elencwajg B, et al. - Given that endocardial cardiac resynchronization therapy (eCRT) circumvents the limitations and failures of coronary sinus (CS) resynchronization, researchers sought to report data regarding long-term outcomes of eCRT performed using the Jurdham procedure in a “real world” setting. Patients comprising those who failed a CS implant, failed to respond to cardiac resynchronization therapy (CRT), or selected patients who needed life-long oral anticoagulation, were provided eCRT. Eighty-eight underwent the Jurdham Procedure from August 2009 to March 2018, at 15 centers in 8 countries with a follow up of 32.88 ± 61.52 months (range 0 – 88 months, 196 patient-years). Outcomes support the safety and efficacy of providing eCRT using the Jurdham Procedure in anticoagulated patients. This suggests eCRT as an attractive approach for patients with failed CS implants or non-responders to CS CRT and as a reasonable approach being the first option for patients needing life-long OAC.